Package 27241-158-60

Brand: valganciclovir

Generic: valganciclovir
NDC Package

Package Facts

Identity

Package NDC 27241-158-60
Digits Only 2724115860
Product NDC 27241-158
Product ID 27241-158_f537ddb1-f868-4bef-937b-e520b04e26a0
Description

60 TABLET in 1 BOTTLE (27241-158-60)

Marketing

Marketing Status
Marketed Since 2019-12-26
Brand valganciclovir
Generic valganciclovir
Sample Package No

Linked Drug Pages (1)

Valganciclovir ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f537ddb1-f868-4bef-937b-e520b04e26a0", "openfda": {"upc": ["0327241158605"], "unii": ["4P3T9QF9NZ"], "rxcui": ["313566"], "spl_set_id": ["d13cc8ad-eaf0-4ae6-89da-a850a08b1067"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (27241-158-60)", "package_ndc": "27241-158-60", "marketing_start_date": "20191226"}], "brand_name": "Valganciclovir", "product_id": "27241-158_f537ddb1-f868-4bef-937b-e520b04e26a0", "dosage_form": "TABLET", "pharm_class": ["Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "DNA Polymerase Inhibitors [MoA]", "Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "27241-158", "generic_name": "Valganciclovir", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valganciclovir", "active_ingredients": [{"name": "VALGANCICLOVIR HYDROCHLORIDE", "strength": "450 mg/1"}], "application_number": "ANDA212234", "marketing_category": "ANDA", "marketing_start_date": "20191226", "listing_expiration_date": "20271231"}